*Game-Changer in HIV Prevention: US Approves Biannual Shot. June 20 2025* The US has approved Gilead’s new HIV prevention shot, Lenacapavir (brand name: Yeztugo) — taken just twice a year. Clinical trials show it’s over 99.9% effective, offering a powerful new option in the fight against HIV. ^JMI